Clinical trials: Venom Allergy
Hymenoptera Venom Allergy
Virtual-reality Induced Immune Modulation in Allergic Patients
This study investigates whether immersive virtual reality (VR) exposure to allergen-related stimuli can modulate behavioural, neurophysiological, psychophysiological, and immune responses in adults with bee or wasp venom allergy.
- Trial name
- NCT07721233
- Testing
- Allergen-related immersive virtual reality exposure, Control immersive virtual reality exposure
- Volunteers
- 81 people, healthy volunteers welcome
- Sponsor
- University of Geneva, Switzerland
Pollen Allergy, Venom Allergy
Identification of B Regulatory Cells by Flow Cytometry
The goal of this laboratory and observational study is to develop a test to quantify B-regulatory cells in blood. This will be used to detect changes in B-regulatory cell populations in pollen and insect venom allergic patients…
- Trial name
- NCT06876506
- Testing
- Venepuncture, Allergen Specific Immunotherapy
- Where
- United Kingdom
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Hull University Teaching Hospitals NHS Trust
Allergy Testing, Peanut Allergies
BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)
The goal of this exploratory pilot study is to generate early data needed for future validation studies of the automated BÜHLMANN BAT (Basophil activation test) assay.
- Conditions
- Allergy Testing, Peanut Allergies, Venom Allergy, House Dust Mite Allergy
- Trial name
- NCT07596303
- Where
- Germany
- Volunteers
- 38 people
- Sponsor
- Bühlmann Laboratories AG
Allergy
Efficacy and Safety of a Purified Standardised Wasp Venom Preparation
The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy
- Trial name
- NCT00263926
- Testing
- wasp venom
- Where
- Germany
- Sponsor
- Allergopharma GmbH & Co. KG
Hypersensitivity, Immediate, Insect Bites and Stings
The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
The investigators wish to evaluate the association between tryptase values as well as c-Kit mutation and adverse effects in the course of immunotherapy.
- Conditions
- Hypersensitivity, Immediate, Insect Bites and Stings, Mastocytosis
- Trial name
- NCT02503800
- Where
- Israel
- Volunteers
- 159 people
- Sponsor
- Meir Medical Center
Idiopathic Anaphylaxis, Drug Anaphylaxis
Cause of Unexplained Anaphylaxis
This study will explore the possible cause of unexplained, or idiopathic, anaphylaxis. Anaphylaxis is a rapid, life-threatening, severe reaction that occurs suddenly after contact with an allergy-causing substance, usually a…
- Conditions
- Idiopathic Anaphylaxis, Drug Anaphylaxis, Venom Anaphylaxis, Food Anaphylaxis
- Trial name
- NCT00719719
- Where
- United States
- Volunteers
- 115 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Hymenoptera Allergy
Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy
Currently, most of the protocols used for desensitization to Hymenoptera venoms consist of a very rapid increase in doses of venom extracts administered during the SIT in a day without systemic reaction of the patient which is…
- Trial name
- MAISAVEN (NCT02295488)
- Testing
- biological sampling, Desensitization protocol (Alyostall®)
- Where
- France
- Volunteers
- 29 people
- Sponsor
- University Hospital, Rouen
Vespid Venom Allergy
Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)
Insect venom allergy is the major cause for severe allergic reactions in Europe. Wasps and honeybees are responsible for the majority of these allergic reactions.
- Trial name
- NCT04438525
- Testing
- sting challenge, blood donation
- Where
- Austria
- Volunteers
- 219 people
- Sponsor
- Medical University of Graz
Bee Venom Allergy
Efficacy and Safety of a Purified Standardised Bee Venom Preparation
The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy
- Trial name
- NCT00263952
- Testing
- bee venom
- Where
- Germany
- Sponsor
- Allergopharma GmbH & Co. KG
Bee Venom Allergy
Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure
Venom immunotherapy (VIT) is an established treatment for Hymenoptera venom allergy and provides long-term protection from further generalized reactions in almost all patients.
- Trial name
- PREDICT (NCT04259359)
- Testing
- Insect Venom
- Where
- 3 sites in Austria, Germany and 1 more
- Volunteers
- 266 people
- Sponsor
- Medical University of Graz
Anaphylaxis Caused by Hymenoptera Venom (Disorder)
Hymenoptera Venom Immunotherapy: Evaluation of Its Long-term Efficacy at the University Hospital of Angers (EFLOTITA2)
Allergy to Hymenoptera venom is one of the main causes of anaphylaxis in adults, and is less common in the paediatric population. It can be severe or even fatal.
- Trial name
- EFLOTITA2 (NCT05311644)
- Testing
- Telephone survey
- Where
- France
- Volunteers
- 290 people
- Sponsor
- University Hospital, Angers
Allergy to Arthropod Sting
Comparison of Skin Prick Testing and Intradermal Skin Test Result of Local and Imported Insect Allergen Extracts
Comparison the results of skin prick testing and Intradermal skin test result of local and imported insect allergen extracts in patients with serious insect sting allergy reactions
- Trial name
- NCT03645291
- Testing
- Local insect allergen extracts skin test
- Where
- Thailand
- Volunteers
- 27 people
- Sponsor
- Mahidol University
Birch Pollen Allergy, Grass Pollen Allergy
Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens
About 20% of the general population are affected by an allergy - with an upward trend. Quite often, allergic people do not consider their disease as serious and suffer from subsequent complications, like allergic asthma, later in…
- Conditions
- Birch Pollen Allergy, Grass Pollen Allergy, House Dust Mite Allergy, Cat Allergy
- Trial name
- MADMAX (NCT04435678)
- Testing
- ALEX² test using the MAX 45k automated laboratory system
- Where
- 2 sites in Austria
- Volunteers
- 839 people
- Sponsor
- MacroArray Diagnostics GmbH
Hymenoptera Venom Allergy, Antihypertensive Treatment
The Effect of Antihypertensive Drugs on Severity of Anaphylaxis and Side-effects During Venom Immunotherapy
There is an ongoing debate whether antihypertensive treatment with beta-blockers and/or angiotensin converting Enzyme (ACE)-inhibitors comprises a risk factor for more severe and more frequent side-effects during venom…
- Trial name
- EADOAS (NCT04269629)
- Testing
- Insect Venom
- Where
- Austria
- Volunteers
- 1,425 people
- Sponsor
- Medical University of Graz
Hymenoptera Venom Allergy
Regulation of Blood Dendritic Cells During Immune Therapy for Hymenoptera Venom Allergy
Dendritic cells (DC) play a key role in the pathogenesis of allergic diseases. The regulation of blood dendritic cells in patients with hymenoptera venom allergy before and during immune therapy is unknown.
- Trial name
- NCT00947908
- Testing
- Hymenoptera venom
- Where
- Germany
- Volunteers
- 20 people
- Sponsor
- University of Rostock
Wasp Venom Allergic Patients
Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
To determine which subclass of IgG in the serum of patients undergoing SIT against wasp venom is able to neutralize the allergen, and therefore to prevent a positive CAST
- Trial name
- NCT00794287
- Testing
- Taking blood samples
- Where
- Switzerland
- Sponsor
- University of Zurich
Allergy, Immunotherapy
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Jack Jumper ant (JJA) venom allergy is a uniquely Australian medical condition. It is the leading cause of venom allergy and affects up to three per cent of the population.
- Conditions
- Allergy, Immunotherapy, Venom Allergy
- Trial name
- JAVELIN (NCT06935890)
- Testing
- Jack Jumper Ant Venom Immunotherapy
- Where
- 3 sites in Australia
- Volunteers
- 100 people
- Sponsor
- Murdoch Childrens Research Institute
Allergy, Insect Venom, Allergy Insect Stinging
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings.
- Conditions
- Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
- Trial name
- Venox-23 (NCT06790368)
- Testing
- VENOX
- Where
- 3 sites in Spain
- Volunteers
- 80 people
- Sponsor
- Inmunotek S.L.
Allergy to Himenoptera Venom
Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom
It is a safety and tolerability study of Allergovac Himenopteros in patients sensitized to Apis mellifera, Polistes Dominula or Vespula spp. To get this aim all adverse reactions will be recorded through the study.
- Trial name
- HIPNOS (NCT04112797)
- Testing
- Allergovac himenoptera
- Where
- 8 sites in Spain
- Volunteers
- 50 people
- Sponsor
- Roxall Medicina España S.A
Insect Sting Allergy
The Causative Insects in Severe Insect Sting Allergy
Study the causative insect by skin prick test and sIgE to wasp, bee and fire ants are important but false positive by crossreactivity can occur.
- Trial name
- NCT02764242
- Testing
- Skin prick test, sIgE measurement
- Volunteers
- 20 people
- Sponsor
- Mahidol University